Barclays’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4432 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4445 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4408 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4368 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4240 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4205 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4258 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4305 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4303 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4347 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4432 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4721 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4798 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4797 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$3K | – | 4233 |
|
|
2019
Q2 | $3K | Hold |
1
| – | – | ﹤0.01% | 4113 |
|
|
2019
Q1 | $19K | Sell |
1
-2
| -67% | -$38K | ﹤0.01% | 3922 |
|
|
2018
Q4 | $50K | Buy |
3
+2
| +200% | +$33.3K | ﹤0.01% | 3174 |
|
|
2018
Q3 | $31K | Hold |
1
| – | – | ﹤0.01% | 3849 |
|
|
2018
Q2 | $67K | Hold |
1
| – | – | ﹤0.01% | 3204 |
|
|
2018
Q1 | $125K | Hold |
1
| – | – | ﹤0.01% | 3070 |
|
|
2017
Q4 | $106K | Hold |
1
| – | – | ﹤0.01% | 2969 |
|
|
2017
Q3 | $153K | Hold |
1
| – | – | ﹤0.01% | 2515 |
|
|
2017
Q2 | $170K | Buy |
+1
| New | +$170K | ﹤0.01% | 2530 |
|
|
2017
Q1 | – | Hold |
0
| – | -$145K | – | 2458 |
|
|
2016
Q4 | – | Hold |
0
| – | -$28K | – | 2452 |
|
|
2016
Q3 | – | Hold |
0
| – | -$27K | – | 2929 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 2748 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3532 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3416 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4011 |
|
|
2015
Q2 | – | Hold |
0
| – | -$1K | – | 4127 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3987 |
|